BIOSPECIFICS TECHNOLOGIES CORP Deferred Revenue
BIOSPECIFICS TECHNOLOGIES CORP had Deferred Revenue of $6.40 million as of 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2018-03-14
- 2017-12-31: Deferred Revenue $6.40M.
- 2017-09-30: Deferred Revenue $6.70M.
- 2017-06-30: Deferred Revenue $7.00M.
- 2017-03-31: Deferred Revenue $7.30M.
| Period end | Deferred Revenue | Deferred Revenue as first filed |
|---|---|---|
| 2017-12-31 | $6.40M 10-K · filed 2018-03-14 | |
| 2017-09-30 | $6.70M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $7.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $7.30M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $7.60M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $7.90M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.20M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.40M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $200.00K 10-K · filed 2017-03-16 | $198.76K 10-K · filed 2016-03-14 |
| 2015-09-30 | $111.10K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $123.45K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $135.79K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $148.13K 10-K · filed 2016-03-14 | |
| 2013-12-31 | $207.39K 10-K · filed 2015-03-16 | $100.00K 10-K · filed 2014-03-07 |
| 2012-12-31 | $100.00K 10-K · filed 2014-03-07 |